Protillion Biosciences
Carlsbad, US · 2 known investors
Protillion is a biotech company that appears to focus on antibody engineering and platform technology for drug development. The company employs scientists, bioinformaticians, and hardware engineers to develop tools and platforms in the life sciences space.
AI & Machine LearningBiotechDeep Tech
Founders & leadership
RH
Robert HollingsworthChief Scientific Officer
CL
Curtis LaytonCEO/Co-Founder
DW
David WaltCo-Founder
WG
Will GreenleafCo-Founder
Investors · 2
In the news
- Historic Biotech IPO, Merck, Protillion’s AI Deal, Testing a Lassa–Rabies Vaccinegenengnews.com · 2026
- CollectiveMinds LLC Places Robert Hollingsworth, PhD as Chief Scientific Officer of Protillion Biosciencesfinance.yahoo.com · 2026
- Protillion Biosciences Raises $18 Million Series A Financing Led by ARCH Venture Partners and Illumina Ventures - BioSpacebiospace.com · 2022
- Protillion - 2025 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Protillion Biosciences - Tech Company Profile - Gaebler.com Venture Capital Databasegaebler.com
- Protillion Biosciences 12/19/2022 Capital Raise - Gaebler.com Venture Capital Databasegaebler.com